Cargando…
Genome mining for drug discovery: progress at the front end
Microbial genome mining for drug discovery and development has been accelerating in recent years, driven by technical advancements in genome sequencing, bioinformatics, metabolomics/metabologenomics, and synthetic biology. Microbial genome mining is a multistep process that starts with the sequencin...
Autor principal: | Baltz, Richard H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788784/ https://www.ncbi.nlm.nih.gov/pubmed/34279640 http://dx.doi.org/10.1093/jimb/kuab044 |
Ejemplares similares
-
Genome mining for drug discovery: cyclic lipopeptides related to daptomycin
por: Baltz, Richard H
Publicado: (2021) -
Discovery of ammosesters by mining the Streptomyces uncialis DCA2648 genome revealing new insight into ammosamide biosynthesis
por: Luo, Jun, et al.
Publicado: (2021) -
Micrococcus spp. as a promising source for drug discovery: A review
por: Tizabi, Daniela, et al.
Publicado: (2023) -
Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture
por: Kim, Ji Hun, et al.
Publicado: (2021) -
Discovery of an alternative pathway of peptidoglycan biosynthesis: A new target for pathway specific inhibitors
por: Ogasawara, Yasushi, et al.
Publicado: (2021)